547 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Acquired by Fragasso Group Inc.

Fragasso Group Inc. purchased a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 1st quarter, Holdings Channel.com reports. The institutional investor purchased 547 shares of the medical equipment provider’s stock, valued at approximately $218,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in ISRG. Norges Bank acquired a new position in shares of Intuitive Surgical in the fourth quarter valued at about $1,313,238,000. WCM Investment Management LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $575,536,000. International Assets Investment Management LLC grew its position in shares of Intuitive Surgical by 32,360.5% during the 4th quarter. International Assets Investment Management LLC now owns 686,865 shares of the medical equipment provider’s stock worth $231,721,000 after purchasing an additional 684,749 shares in the last quarter. Alphinity Investment Management Pty Ltd increased its holdings in shares of Intuitive Surgical by 113.2% during the fourth quarter. Alphinity Investment Management Pty Ltd now owns 1,276,158 shares of the medical equipment provider’s stock worth $430,525,000 after purchasing an additional 677,455 shares during the period. Finally, Coatue Management LLC raised its position in shares of Intuitive Surgical by 65.7% in the fourth quarter. Coatue Management LLC now owns 1,301,595 shares of the medical equipment provider’s stock valued at $439,106,000 after buying an additional 516,054 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $432.56 on Friday. The company’s 50 day moving average price is $397.13 and its two-hundred day moving average price is $378.19. The firm has a market capitalization of $153.43 billion, a P/E ratio of 78.08, a P/E/G ratio of 5.59 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $254.85 and a fifty-two week high of $437.20.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.10. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The company had revenue of $1.89 billion for the quarter, compared to the consensus estimate of $1.87 billion. During the same quarter last year, the business posted $1.00 EPS. Intuitive Surgical’s revenue for the quarter was up 11.5% on a year-over-year basis. On average, analysts expect that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the company. Citigroup increased their price target on Intuitive Surgical from $428.00 to $462.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. Robert W. Baird reduced their target price on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a report on Friday, April 19th. BTIG Research boosted their price target on Intuitive Surgical from $412.00 to $421.00 and gave the company a “buy” rating in a research note on Friday, April 19th. The Goldman Sachs Group began coverage on shares of Intuitive Surgical in a research note on Thursday, May 30th. They set a “buy” rating and a $500.00 price objective on the stock. Finally, Piper Sandler raised their target price on shares of Intuitive Surgical from $425.00 to $435.00 and gave the company an “overweight” rating in a report on Friday, April 19th. Five research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $403.67.

Insider Activity

In other news, Director Alan J. Levy sold 2,000 shares of the company’s stock in a transaction that occurred on Tuesday, April 23rd. The stock was sold at an average price of $370.70, for a total value of $741,400.00. Following the completion of the transaction, the director now owns 25,319 shares of the company’s stock, valued at $9,385,753.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In related news, Director Alan J. Levy sold 2,000 shares of the business’s stock in a transaction on Tuesday, April 23rd. The shares were sold at an average price of $370.70, for a total value of $741,400.00. Following the sale, the director now owns 25,319 shares of the company’s stock, valued at $9,385,753.30. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Craig H. Barratt sold 1,400 shares of the stock in a transaction on Wednesday, June 12th. The shares were sold at an average price of $421.06, for a total value of $589,484.00. The disclosure for this sale can be found here. Over the last three months, insiders have sold 17,956 shares of company stock valued at $6,927,011. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.